Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
the Wild in Style: The Reduced Portage Mustang's Bold Heritage - 2Israel says Iran's military industry will be destroyed 'within days'
- 3Instructions to Arrange Your Compensation During Medical caretaker Prospective employee meetings
- 4An Investigate of 6 Creative Specialty Mixed drinks
- 5At least 55 injured in Russia after train crashes, overturns
- Sound Maturing: Wellbeing Tips for Each Life Stage
- Clovis Unified students spend spring break traveling through China
- Astronomers detect black hole blasting winds at incredible speeds
- 2 bright planets light up April evenings — here's where and when to look
- Lebanon says Israeli strike killed 13 people near Palestinian refugee camp
- At least 30 killed in attack on Nigeria village
- Flu illness count nears 5 million, with New York City among the hardest hit
- AstraZeneca to invest $2 billion as part of US manufacturing push
- Novo Nordisk slashes prices of popular weight loss and diabetes drugs
